Detailed View
IRWD - Ironwood Pharmaceuticals, Inc.
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
598,168,576
Adj EBIT (TTM)
248,493,000
Enterprise Value
519,041,576
Last Price
3.62
Earnings Yield
47.88%
Return on Capital
99.14%
Capital
250,641,000
1Y Price Chart
Last Price: $3.62
1Y Change: 135.06%
As of 2026-10-29 | 1Y Change: 135.06%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 113,041,000 | 79,307,000 |
| 2026-03-31 | 10-Q | 2026 | 106,506,000 | 72,573,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 47,709,000 | 6,805,000 |
| 2025-09-30 | 10-Q | 2025 | 122,060,000 | 75,484,000 |
| 2025-06-30 | 10-Q | 2025 | 85,239,000 | 45,321,000 |
| 2025-03-31 | 10-Q | 2025 | 41,143,000 | -29,108,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 90,545,000 | 31,491,000 |
| 2024-09-30 | 10-Q | 2024 | 91,592,000 | 25,636,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.